Ghamande S - Search Results

1

Evaluation of prognostic factors and treatment modalities in ovarian cancer patients with brain metastases.

Anupol N, Ghamande S, Odunsi K, Driscoll D, Lele S. Anupol N, et al. Among authors: ghamande s. Gynecol Oncol. 2002 Jun;85(3):487-92. doi: 10.1006/gyno.2002.6653. Gynecol Oncol. 2002. PMID: 12051879

2

Prospective evaluation of the tolerability and efficacy of niraparib dosing based on baseline body weight and platelet count: Results from the PRIMA/ENGOT-OV26/GOG-3012 trial.

Mirza MR, González-Martín A, Graybill WS, O'Malley DM, Gaba L, Stephanie Yap OW, Guerra EM, Rose PG, Baurain JF, Ghamande SA, Denys H, Prendergast E, Pisano C, Follana P, Baumann K, Calvert PM, Korach J, Li Y, Malinowska IA, Gupta D, Monk BJ. Mirza MR, et al. Among authors: ghamande sa. Cancer. 2023 Jun 15;129(12):1846-1855. doi: 10.1002/cncr.34706. Epub 2023 Apr 14. Cancer. 2023. PMID: 37060236 Clinical Trial.

3

Safety, Efficacy, and Biomarker Analyses of Dostarlimab in Patients with Endometrial Cancer: Interim Results of the Phase I GARNET Study.

Oaknin A, Pothuri B, Gilbert L, Sabatier R, Brown J, Ghamande S, Mathews C, O'Malley DM, Kristeleit R, Boni V, Gravina A, Banerjee S, Miller R, Pikiel J, Mirza MR, Dewal N, Antony G, Dong Y, Zografos E, Veneris J, Tinker AV. Oaknin A, et al. Among authors: ghamande s. Clin Cancer Res. 2023 Nov 14;29(22):4564-4574. doi: 10.1158/1078-0432.CCR-22-3915. Clin Cancer Res. 2023. PMID: 37363992 Free PMC article.

4

Maveropepimut-S, a DPX-Based Immune-Educating Therapy, Shows Promising and Durable Clinical Benefit in Patients with Recurrent Ovarian Cancer, a Phase II Trial.

Dorigo O, Oza AM, Pejovic T, Ghatage P, Ghamande S, Provencher D, MacDonald LD, Torrey H, Kaliaperumal V, Ebrahimizadeh W, Hirsch HA, Bramhecha Y, Villella J, Fiset S. Dorigo O, et al. Among authors: ghamande s. Clin Cancer Res. 2023 Aug 1;29(15):2808-2815. doi: 10.1158/1078-0432.CCR-22-2595. Clin Cancer Res. 2023. PMID: 37126016 Free PMC article. Clinical Trial.

5

Role of salvage chemotherapy with topotecan and cisplatin in patients with paclitaxel- and platinum-resistant recurrent ovarian or primary peritoneal cancer: a phase II pilot study.

Ghamande SA, Piver MS. Ghamande SA, et al. J Surg Oncol. 1999 Nov;72(3):162-6. doi: 10.1002/(sici)1096-9098(199911)72:3<162::aid-jso9>3.0.co;2-0. J Surg Oncol. 1999. PMID: 10562363 Clinical Trial.

6

First-line chemotherapy with paclitaxel and platinum for advanced and recurrent cancer of the cervix--a phase II study.

Piver MS, Ghamande SA, Eltabbakh GH, O'Neill-Coppola C. Piver MS, et al. Among authors: ghamande sa. Gynecol Oncol. 1999 Dec;75(3):334-7. doi: 10.1006/gyno.1999.5586. Gynecol Oncol. 1999. PMID: 10600285 Clinical Trial.

7

Recombinant CD40 ligand therapy has significant antitumor effects on CD40-positive ovarian tumor xenografts grown in SCID mice and demonstrates an augmented effect with cisplatin.

Ghamande S, Hylander BL, Oflazoglu E, Lele S, Fanslow W, Repasky EA. Ghamande S, et al. Cancer Res. 2001 Oct 15;61(20):7556-62. Cancer Res. 2001. PMID: 11606394

8

The impact of pre-therapy extraperitoneal surgical staging on the evaluation and treatment of patients with locally advanced cervical cancer.

Odunsi KO, Lele S, Ghamande S, Seago P, Driscoll DL. Odunsi KO, et al. Among authors: ghamande s. Eur J Gynaecol Oncol. 2001;22(5):325-30. Eur J Gynaecol Oncol. 2001. PMID: 11766731

9

Evaluation of beta1,4-galactosyltransferase as a potential biomarker for the detection of subclinical disease after the completion of primary therapy for ovarian cancer.

Odunsi K, Ghamande S, Chandrasekaran EV, Ta A, Moysich KB, Driscoll D, Matta K, Lele S. Odunsi K, et al. Among authors: ghamande s. Am J Obstet Gynecol. 2002 Sep;187(3):575-80. doi: 10.1067/mob.2002.125888. Am J Obstet Gynecol. 2002. PMID: 12237630

10

Weekly paclitaxel in patients with recurrent or persistent advanced ovarian cancer.

Ghamande S, Lele S, Marchetti D, Baker T, Odunsi K. Ghamande S, et al. Int J Gynecol Cancer. 2003 Mar-Apr;13(2):142-7. doi: 10.1046/j.1525-1438.2003.13045.x. Int J Gynecol Cancer. 2003. PMID: 12657114 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

166 results

Search Page